Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1 889.1 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
other: ECHA factors in combination with recent scientific literature
Overall assessment factor (AF):
8.4
Dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Modified dose descriptor starting point:
NOAEC
Value:
15 868 mg/m³
Explanation for the modification of the dose descriptor starting point:

Key OECD 422 oral toxicity study available; no repeated dose inhalation toxicity study available.

AF for dose response relationship:
1
Justification:
Different doses were tested in the various studies, therefore no additional factor is used.
AF for differences in duration of exposure:
1.4
Justification:
The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
AF for interspecies differences (allometric scaling):
1
Justification:
Allometric scaling is already applied in route-to-route extrapolation.
AF for other interspecies differences:
1
Justification:
No toxicodynamic differences between species; see justification attached.
AF for intraspecies differences:
2.4
Justification:
Refined assessment of population differences; see justification attached.
AF for the quality of the whole database:
1
Justification:
Results were based on key Klimisch 1-2 studies (and possible supporting studies).
AF for remaining uncertainties:
2.5
Justification:
For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
267.86 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
other: ECHA factors in combination with recent scientific literature
Overall assessment factor (AF):
33.6
Dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
9 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:

Key 28-55-day (OECD 422) oral toxicity study available; no repeated dose dermal toxicity study available.

AF for dose response relationship:
1
Justification:
Different doses were tested in the various studies, therefore no additional factor is used.
AF for differences in duration of exposure:
1.4
Justification:
Extrapolation from subchronic to chronic; see justification attached.
AF for interspecies differences (allometric scaling):
4
Justification:
ECHA default allometric scaling factor for the differences between rats and humans is used.
AF for other interspecies differences:
1
Justification:
No toxicodynamic differences between species; see justification attached.
AF for intraspecies differences:
2.4
Justification:
Refined assessment of population differences; see justification attached.
AF for the quality of the whole database:
1
Justification:
Results were based on key Klimisch 1-2 studies (and possible supporting studies).
AF for remaining uncertainties:
2.5
Justification:
For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
Acute/short term exposure
Hazard assessment conclusion:
no DNEL required: short term exposure controlled by conditions for long-term

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
medium hazard (no threshold derived)

Additional information - workers

The following source information was taken into account for DNEL calculation:


Subacute toxicity was tested with the registered substance in Wistar rats by oral gavage at 0 (vehicle), 100, 300 and 1000 mg/kg bw/day in a supporting 14-day dose range finding and in a key combined repeated dose/reproductive toxicity study (OECD No. 422). The vehicle was distilled water in the 14-day dose range finding and propylene glycol in the OECD 422 study. In the OECD 422 study, the test item did not result in test item related mortality. Test item related noisy respiration was observed sporadic cases in a few animals ascribed to reflux or minor exposure to test item in the region of the upper respiratory tract. The bodyweight, body weight gain, and food consumption of the test item treated groups did not show any test item related effect. At the functional observation battery (FOB), locomotor activity measurement, grip strength and foot splay, there were no effects. There were no changes in animal behaviour or general physical condition in the control or test groups. No test item-related findings were seen in the clinical pathology parameters. Minimal to marked multifocal squamous cell hyperplasia and minimal to mild erosion/ulcer, diffuse minimal to mild infiltrates in non-glandular stomach were observed in the High dose males and females. No other adverse test item related systemic macroscopic or microscopic changes were recorded at necropsy or at histopathology evaluation of routine organs/tissues or in any reproductive organs. The NOAEL for local toxicity of the parental generation was 300 mg/kg bw/day (based on local gastric effects). The NOAEL for systemic toxicity of the parental generation was 1000 mg/kg bw/day (based on no significant findings).


No test item effect on oestrus cycle of parental females was noted. No test item related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD14. There were no adverse effects on the F1 offspring viability, clinical signs, physical or sexual development. No test item related macroscopic findings were recorded for F1 pups at necropsy. Minimal to marked multifocal squamous cell hyperplasia and minimal to mild erosion/ulcer, diffuse minimal to mild infiltrates in non-glandular stomach were observed in the High dose males and females. No other adverse test item related systemic macroscopic or microscopic changes were recorded at necropsy or at histopathology evaluation of routine organs/tissues or in any reproductive organs. Under the experimental conditions of this study and based on the results of thyroid hormone measurement, thyroid weights, nipple retention, anogenital distance and external reproductive organs analysis, histopathology and reproductive performance, there was no evidence for any endocrine effects. The NOAEL for reproductive effects of the parental generation was considered to be 1000 mg/kg bw/day (based on no significant findings). The NOAEL for pup development and survival was considered to be 1000 mg/kg bw/day (based on no significant findings).


Repeated dose toxicity was further tested in various species, including rats, dogs, rabbits and monkeys. The NOAEL of 750 mg/kg bw/day obtained in the subchronic 90-day dietary toxicity study in rats with registered substance was confirmed to be consistent with data from category members in rats and the NOAEL of 1000 mg/kg bw of Docusate sodium  in a 90-day dietary toxicity study. Other data from other species were tested with read-across substance and were of limited reliability and relevance and therefore not taken into account.


Based on the above information, the NOAEL of 1000 mg/kg bw/day of the OECD 422 study can be considered as most appropriate point of departure for DNEL derivation.

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
559.01 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
other: ECHA factors in combination with recent scientific literature.
Overall assessment factor (AF):
14
Dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Modified dose descriptor starting point:
NOAEC
Value:
7 826 mg/m³
Explanation for the modification of the dose descriptor starting point:

Key 28-55-day (OECD 422) oral toxicity study available; no repeated dose inhalation toxicity study available.

AF for dose response relationship:
1
Justification:
Different doses were tested in the various studies, therefore no additional factor is used.
AF for differences in duration of exposure:
1.4
Justification:
The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
AF for interspecies differences (allometric scaling):
1
Justification:
Allometric scaling is already applied in route-to-route extrapolation.
AF for other interspecies differences:
1
Justification:
No toxicodynamic differences between species; see justification attached.
AF for intraspecies differences:
4
Justification:
Refined assessment of population differences; see justification attached.
AF for the quality of the whole database:
1
Justification:
Results were based on key Klimisch 1-2 studies (and possible supporting studies).
AF for remaining uncertainties:
2.5
Justification:
For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
Acute/short term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
160.71 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
other: ECHA factors in combination with recent scientific literature
Overall assessment factor (AF):
56
Dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
9 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:

Key 28-55-day (OECD 422) oral toxicity study available; no repeated dose dermal toxicity study available.

AF for dose response relationship:
1
Justification:
Different doses were tested in the various studies, therefore no additional factor is used.
AF for differences in duration of exposure:
1.4
Justification:
The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
AF for interspecies differences (allometric scaling):
4
Justification:
ECHA default allometric scaling factor for the differences between rats and humans is used.
AF for other interspecies differences:
1
Justification:
No toxicodynamic differences between species; see justification attached.
AF for intraspecies differences:
4
Justification:
Refined assessment of population differences; see justification attached.
AF for the quality of the whole database:
1
Justification:
Results were based on key Klimisch 1-2 studies (and possible supporting studies).
AF for remaining uncertainties:
2.5
Justification:
For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
hazard unknown (no further information necessary)
Acute/short term exposure
Hazard assessment conclusion:
no DNEL required: short term exposure controlled by conditions for long-term

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
17.86 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
other: ECHA factors in combination with recent scientific literature
Overall assessment factor (AF):
56
Dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
Not applicable
AF for dose response relationship:
1
Justification:
Different doses were tested in the various studies, therefore no additional factor is used.
AF for differences in duration of exposure:
1.4
Justification:
The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
AF for interspecies differences (allometric scaling):
4
Justification:
ECHA default allometric scaling factor for the differences between rats and humans is used.
AF for other interspecies differences:
1
Justification:
No toxicodynamic differences between species; see justification attached.
AF for intraspecies differences:
4
Justification:
Refined assessment of population differences; see justification attached.
AF for the quality of the whole database:
1
Justification:
Results were based on key Klimisch 1-2 studies (and possible supporting studies).
AF for remaining uncertainties:
2.5
Justification:
For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
medium hazard (no threshold derived)

Additional information - General Population

The following source information was taken into account for DNEL calculation:


Subacute toxicity was tested with the registered substance in Wistar rats by oral gavage at 0 (vehicle), 100, 300 and 1000 mg/kg bw/day in a supporting 14-day dose range finding and in a key combined repeated dose/reproductive toxicity study (OECD No. 422). The vehicle was distilled water in the 14-day dose range finding and propylene glycol in the OECD 422 study. In the OECD 422 study, the test item did not result in test item related mortality. Test item related noisy respiration was observed sporadic cases in a few animals ascribed to reflux or minor exposure to test item in the region of the upper respiratory tract. The bodyweight, body weight gain, and food consumption of the test item treated groups did not show any test item related effect. At the functional observation battery (FOB), locomotor activity measurement, grip strength and foot splay, there were no effects. There were no changes in animal behaviour or general physical condition in the control or test groups. No test item-related findings were seen in the clinical pathology parameters. Minimal to marked multifocal squamous cell hyperplasia and minimal to mild erosion/ulcer, diffuse minimal to mild infiltrates in non-glandular stomach were observed in the High dose males and females. No other adverse test item related systemic macroscopic or microscopic changes were recorded at necropsy or at histopathology evaluation of routine organs/tissues or in any reproductive organs. The NOAEL for local toxicity of the parental generation was 300 mg/kg bw/day (based on local gastric effects). The NOAEL for systemic toxicity of the parental generation was 1000 mg/kg bw/day (based on no significant findings).


No test item effect on oestrus cycle of parental females was noted. No test item related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD14. There were no adverse effects on the F1 offspring viability, clinical signs, physical or sexual development. No test item related macroscopic findings were recorded for F1 pups at necropsy. Minimal to marked multifocal squamous cell hyperplasia and minimal to mild erosion/ulcer, diffuse minimal to mild infiltrates in non-glandular stomach were observed in the High dose males and females. No other adverse test item related systemic macroscopic or microscopic changes were recorded at necropsy or at histopathology evaluation of routine organs/tissues or in any reproductive organs. Under the experimental conditions of this study and based on the results of thyroid hormone measurement, thyroid weights, nipple retention, anogenital distance and external reproductive organs analysis, histopathology and reproductive performance, there was no evidence for any endocrine effects. The NOAEL for reproductive effects of the parental generation was considered to be 1000 mg/kg bw/day (based on no significant findings). The NOAEL for pup development and survival was considered to be 1000 mg/kg bw/day (based on no significant findings).


Repeated dose toxicity was further tested in various species, including rats, dogs, rabbits and monkeys. The NOAEL of 750 mg/kg bw/day obtained in the subchronic 90-day dietary toxicity study in rats with registered substance was confirmed to be consistent with data from category members in rats and the NOAEL of 1000 mg/kg bw of Docusate sodium  in a 90-day dietary toxicity study. Other data from other species were tested with read-across substance and were of limited reliability and relevance and therefore not taken into account.


Based on the above information, the NOAEL of 1000 mg/kg bw/day of the OECD 422 study can be considered as most appropriate point of departure for DNEL derivation.